What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Alzheimer's disease
- Pathology
His primary areas of study are Alzheimer's disease, Pathology, Internal medicine, Dementia and Neuroscience.
His work carried out in the field of Alzheimer's disease brings together such families of science as Biomarker, Predictive value of tests and Retrospective cohort study.
His work on Cerebrospinal fluid, Tau protein and Cohort study as part of general Pathology study is frequently linked to Hyperphosphorylation, bridging the gap between disciplines.
The various areas that Michael Ewers examines in his Internal medicine study include Gastroenterology, Endocrinology and Cardiology.
His research in Dementia intersects with topics in Voxel, Magnetic resonance imaging, Neuropsychology and Atrophy.
His studies deal with areas such as Voxel-based morphometry, Feature and Audiology as well as Neuroscience.
His most cited work include:
- CSF biomarkers and incipient Alzheimer disease in patients with mild cognitive impairment. (893 citations)
- CSF phosphorylated tau protein correlates with neocortical neurofibrillary pathology in Alzheimer's disease (461 citations)
- Prediction of conversion from mild cognitive impairment to Alzheimer's disease dementia based upon biomarkers and neuropsychological test performance (303 citations)
What are the main themes of his work throughout his whole career to date?
Michael Ewers mostly deals with Disease, Internal medicine, Pathology, Neuroscience and Dementia.
His Disease research incorporates themes from Cognition, Immunology and Atrophy.
His research investigates the link between Internal medicine and topics such as Endocrinology that cross with problems in Amyloidosis.
His Pathology research is multidisciplinary, incorporating elements of White matter and Hyperintensity.
He has researched Dementia in several fields, including Apolipoprotein E, Neurology, Neurodegeneration and Gerontology.
His research integrates issues of Predictive value of tests, Psychiatry, Cognitive disorder and Audiology in his study of Alzheimer's disease.
He most often published in these fields:
- Disease (46.55%)
- Internal medicine (37.93%)
- Pathology (31.03%)
What were the highlights of his more recent work (between 2019-2021)?
- Disease (46.55%)
- Internal medicine (37.93%)
- Cognition (14.66%)
In recent papers he was focusing on the following fields of study:
Michael Ewers mainly investigates Disease, Internal medicine, Cognition, Amyloid and Dementia.
His Disease study combines topics in areas such as Precision medicine, Neuroscience and Atrophy.
His Internal medicine research includes elements of Endocrinology and Oncology.
His Amyloid research entails a greater understanding of Pathology.
His work deals with themes such as White matter, Hyperintensity and Diffusion MRI, which intersect with Pathology.
The Dementia study combines topics in areas such as Hazard ratio, Confidence interval, Hippocampal formation, Apolipoprotein E and Neurology.
Between 2019 and 2021, his most popular works were:
- Whitepaper: Defining and investigating cognitive reserve, brain reserve, and brain maintenance (213 citations)
- The BDNF Val66Met SNP modulates the association between beta-amyloid and hippocampal disconnection in Alzheimer’s disease (26 citations)
- Age-dependent amyloid deposition is associated with white matter alterations in cognitively normal adults during the adult life span. (12 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Alzheimer's disease
- Disease
Michael Ewers mainly focuses on Internal medicine, Disease, Cognition, TREM2 and Cognitive decline.
He works in the field of Internal medicine, focusing on Biomarker in particular.
His Biomarker research integrates issues from Endocrinology, Cerebrospinal fluid, Immune system, Beta and Amyloidosis.
Michael Ewers works mostly in the field of Disease, limiting it down to concerns involving Neuroscience and, occasionally, Tau pathology and SNP.
Michael Ewers works mostly in the field of Cognition, limiting it down to topics relating to Oncology and, in certain cases, Sample size determination, Atrophy, Fluorodeoxyglucose and Clinical trial, as a part of the same area of interest.
His study on Cognitive decline is covered under Dementia.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
